Lizhi Cao
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
Papers in
-
- Inflammasome and immune disorders 6
- Glycosylation and Glycoproteins Research 4
- Retinoids in leukemia and cellular processes 4
- Cell death mechanisms and regulation 4
- Epidemiology 15
- Autophagy in Disease and Therapy 13
- Co-authors
- Daolin Tang (29 shared papers)Rui Kang (22 shared papers)Minghua Yang (19 shared papers)Min Xie (18 shared papers)Haichao Wang (11 shared papers)Liangchun Yang (12 shared papers)Timothy R. Billiar (8 shared papers)Michael T. Lotze (5 shared papers)
- Journals
- Autophagy (9 papers)Cancer Research (3 papers)Cell Host & Microbe (2 papers)Nature Communications (2 papers)Leukemia (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Lizhi Cao
46 papers receiving 3.8k citations
Lizhi Cao's Hit Papers
Peers
Comparison fields: 5 of 107
- Clinical Biochemistry 364
- Cancer Research 762
- Immunology 985
- Molecular Biology 2.0k
- Epidemiology 892
Countries citing papers authored by Lizhi Cao
This map shows the geographic impact of Lizhi Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizhi Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizhi Cao more than expected).
Fields of papers citing papers by Lizhi Cao
This network shows the impact of papers produced by Lizhi Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizhi Cao. The network helps show where Lizhi Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Lizhi Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis Hit paper breakdown → | 2018 | 500 |
| 2 | PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation Hit paper breakdown → | 2016 | 449 |
| 3 | 2014 | 414 | |
| 4 | The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents Hit paper breakdown → | 2015 | 396 |
| 5 | 2010 | 217 | |
| 6 | 2020 | 167 | |
| 7 | 2018 | 128 | |
| 8 | 2011 | 124 | |
| 9 | 2014 | 111 | |
| 10 | 2017 | 105 | |
| 11 | 2013 | 93 | |
| 12 | 2012 | 92 | |
| 13 | 2016 | 88 | |
| 14 | 2010 | 76 | |
| 15 | 2012 | 64 | |
| 16 | 2011 | 60 | |
| 17 | 2015 | 56 | |
| 18 | 2011 | 54 | |
| 19 | 2014 | 54 | |
| 20 | 2017 | 50 |
About Lizhi Cao
Lizhi Cao is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Clinical Biochemistry and Immunology, having authored 46 papers that have together received 3.8k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (13 papers), Advanced Glycation End Products research (10 papers), Inflammasome and immune disorders (6 papers), Glycosylation and Glycoproteins Research (4 papers), Retinoids in leukemia and cellular processes (4 papers), Cell death mechanisms and regulation (4 papers), Cancer Research and Treatments (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Clinical Biochemistry (364 citations), Cancer Research (762 citations), Immunology (985 citations), Molecular Biology (2.0k citations) and Epidemiology (892 citations). Lizhi Cao has collaborated with scholars based in China, United States and France. Frequent co-authors include Daolin Tang, Rui Kang, Minghua Yang, Min Xie, Haichao Wang, Liangchun Yang, Timothy R. Billiar, Michael T. Lotze, Ling Zeng and Jianxin Jiang. Their work appears in journals such as Autophagy, Cancer Research, Cell Host & Microbe, Nature Communications and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.